Basic Information
| RNALocate ID: | RLID:11001331 |
| RNA Symbol: | hsa-miR-30c-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-30c-5p |
| RNA ID: | miRBase:MIMAT0000244 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23663360 |
| Tissue/Cell Line: | Plasma |
| Method: | Next-generation RNA sequencing |
| Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001571 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01001572 | Cytoplasm | Cell line (HeLa) | 21695135 |
| RLID:01001573 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001574 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001575 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001576 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001577 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001578 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01001579 | Nucleus | Colon adenocarcinoma cells | 20864815 |
| RLID:01001580 | Nucleus | Neural progenitor cells | 21363885 |
| RLID:11001327 | Exosome | Human cervical cancer cell line (HeLa) | 25760330 |
| RLID:11001328 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11001329 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11001330 | Exosome | Brain tissue | 23382797 |
| RLID:11001332 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11001333 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11000042 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Endothelial cells|Epithelial cells|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue | |
| RLID-D:11000311 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-30c-5p | Splenic marginal zone lymphoma | MNDR-E-MI-37242 |
| MNDR | hsa-miR-30c-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-37243 |
| MNDR | hsa-miR-30c-5p | Glomerulosclerosis | MNDR-E-MI-37244 |
| MNDR | hsa-miR-30c-5p | Oral squamous cell carcinoma | MNDR-E-MI-37245 |
| MNDR | hsa-miR-30c-5p | Large cell neuroendocrine cancer | MNDR-E-MI-37246 |
| MNDR | hsa-miR-30c-5p | Medulloblastoma | MNDR-E-MI-37247 |
| MNDR | hsa-miR-30c-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-37248 |
| MNDR | hsa-miR-30c-5p | Lymphoma | MNDR-E-MI-37249 |
| MNDR | hsa-miR-30c-5p | Lymphoma non-hodgkin | MNDR-E-MI-37250 |
| MNDR | hsa-miR-30c-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-37251 |
| MNDR | hsa-miR-30c-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-37252 |
| MNDR | hsa-miR-30c-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-37253 |
| MNDR | hsa-miR-30c-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-37254 |
| MNDR | hsa-miR-30c-5p | Her2-receptor positive breast cancer | MNDR-E-MI-37255 |
| MNDR | hsa-miR-30c-5p | Niemann-pick disease type c | MNDR-E-MI-37256 |
| MNDR | hsa-miR-30c-5p | Miyoshi myopathy | MNDR-E-MI-37257 |
| MNDR | hsa-miR-30c-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-37258 |
| MNDR | hsa-miR-30c-5p | Dermatomyositis | MNDR-E-MI-37259 |
| MNDR | hsa-miR-30c-5p | Prostate cancer | MNDR-E-MI-37260 |
| MNDR | hsa-miR-30c-5p | Gastric cancer | MNDR-E-MI-37261 |
| MNDR | hsa-miR-30c-5p | Alzheimer disease | MNDR-E-MI-37262 |
| MNDR | hsa-miR-30c-5p | Intracranial aneurysm | MNDR-E-MI-37263 |
| MNDR | hsa-miR-30c-5p | Bladder cancer | MNDR-E-MI-37264 |
| MNDR | hsa-miR-30c-5p | Esophageal carcinoma | MNDR-E-MI-37265 |
| MNDR | hsa-miR-30c-5p | Dysautonomia familial | MNDR-E-MI-37266 |
| MNDR | hsa-miR-30c-5p | Distal muscular dystrophy | MNDR-E-MI-37267 |
| MNDR | hsa-miR-30c-5p | Duchenne muscular dystrophy | MNDR-E-MI-37268 |
| MNDR | hsa-miR-30c-5p | Head and neck cancer | MNDR-E-MI-37269 |
| MNDR | hsa-miR-30c-5p | Huntington disease | MNDR-E-MI-37270 |
| MNDR | hsa-miR-30c-5p | Chorea | MNDR-E-MI-37271 |
| MNDR | hsa-miR-30c-5p | Cardiovascular disease | MNDR-E-MI-37272 |
| MNDR | hsa-miR-30c-5p | Carotid stenosis | MNDR-E-MI-37273 |
| MNDR | hsa-miR-30c-5p | Lung cancer | MNDR-E-MI-37274 |
| MNDR | hsa-miR-30c-5p | Endometrial cancer | MNDR-E-MI-37275 |
| MNDR | hsa-miR-30c-5p | Down syndrome | MNDR-E-MI-37276 |
| MNDR | hsa-miR-30c-5p | Parkinson disease | MNDR-E-MI-37277 |
| MNDR | hsa-miR-30c-5p | Niemann-pick disease | MNDR-E-MI-37278 |
| MNDR | hsa-miR-30c-5p | Breast cancer | MNDR-E-MI-37279 |
| MNDR | hsa-miR-30c-5p | Pancreatic cancer | MNDR-E-MI-37280 |
| MNDR | hsa-miR-30c-5p | Melanoma | MNDR-E-MI-37281 |
| MNDR | hsa-miR-30c-5p | Rectum adenocarcinoma | MNDR-E-MI-37282 |
| MNDR | hsa-miR-30c-5p | Nephroblastoma | MNDR-E-MI-37283 |
| MNDR | hsa-miR-30c-5p | Colon cancer | MNDR-E-MI-37284 |
| MNDR | hsa-miR-30c-5p | Colon adenocarcinoma | MNDR-E-MI-37285 |
| MNDR | hsa-miR-30c-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-37286 |
| MNDR | hsa-miR-30c-5p | Familial ovarian cancer | MNDR-E-MI-37287 |
| MNDR | hsa-miR-30c-5p | Prostate adenocarcinoma | MNDR-E-MI-37288 |
| MNDR | hsa-miR-30c-5p | Cerebellar disease | MNDR-E-MI-37289 |
| MNDR | hsa-miR-30c-5p | Carcinoma ductal breast | MNDR-E-MI-37290 |
| MNDR | hsa-miR-30c-5p | Glioblastoma | MNDR-E-MI-37291 |
| MNDR | hsa-miR-30c-5p | Astrocytoma | MNDR-E-MI-37292 |
| MNDR | hsa-miR-30c-5p | Glioma | MNDR-E-MI-37293 |
| MNDR | hsa-miR-30c-5p | Central nervous system lymphoma | MNDR-E-MI-37294 |
| MNDR | hsa-miR-30c-5p | Chordoma | MNDR-E-MI-37295 |
| MNDR | hsa-miR-30c-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-37296 |
| MNDR | hsa-miR-30c-5p | Osteosarcoma | MNDR-E-MI-37297 |
| MNDR | hsa-miR-30c-5p | Inclusion body myositis | MNDR-E-MI-37298 |
| MNDR | hsa-miR-30c-5p | Meningioma | MNDR-E-MI-37299 |
| MNDR | hsa-miR-30c-5p | Liver cancer | MNDR-E-MI-37300 |
| MNDR | hsa-miR-30c-5p | Gastric adenocarcinoma | MNDR-E-MI-37301 |
| MNDR | hsa-miR-30c-5p | Cervical squamous cell carcinoma | MNDR-E-MI-37302 |
| MNDR | hsa-miR-30c-5p | Lung squamous cell carcinoma | MNDR-E-MI-37303 |
| MNDR | hsa-miR-30c-5p | Carcinoma lung non-small-cell | MNDR-E-MI-37304 |
| MNDR | hsa-miR-30c-5p | Lung adenocarcinoma | MNDR-E-MI-37305 |
| MNDR | hsa-miR-30c-5p | Thyroid carcinoma | MNDR-E-MI-37306 |
| MNDR | hsa-miR-30c-5p | Ovarian carcinoma | MNDR-E-MI-37307 |
| MNDR | hsa-miR-30c-5p | Bladder urothelial carcinoma | MNDR-E-MI-37308 |
| MNDR | hsa-miR-30c-5p | Liver disease | MNDR-E-MI-37309 |
| MNDR | hsa-miR-30c-5p | Carcinoma renal cell | MNDR-E-MI-37310 |
| MNDR | hsa-miR-30c-5p | Clear cell renal cell carcinoma | MNDR-E-MI-37311 |
| MNDR | hsa-miR-30c-5p | Large cell carcinoma | MNDR-E-MI-37312 |
| MNDR | hsa-miR-30c-5p | Biliary tract cancer | MNDR-E-MI-37313 |
| MNDR | hsa-miR-30c-5p | Cholangiocarcinoma | MNDR-E-MI-37314 |
| MNDR | hsa-miR-30c-5p | Esophageal cancer | MNDR-E-MI-37315 |
| MNDR | hsa-miR-30c-5p | Liver cirrhosis | MNDR-E-MI-37316 |
| MNDR | hsa-miR-30c-5p | Lung small cell carcinoma | MNDR-E-MI-37317 |
| MNDR | hsa-miR-30c-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-37318 |
| MNDR | hsa-miR-30c-5p | Heart failure | MNDR-E-MI-37319 |
| MNDR | hsa-miR-30c-5p | Aortic valve disease | MNDR-E-MI-37320 |
| MNDR | hsa-miR-30c-5p | Encephalomyelitis | MNDR-E-MI-37321 |
| MNDR | hsa-miR-30c-5p | Breast invasive carcinoma | MNDR-E-MI-37322 |
| MNDR | hsa-miR-30c-5p | Early hepatocellular carcinoma | MNDR-E-MI-37323 |
| MNDR | hsa-miR-30c-5p | Familiar ovarian carcinoma | MNDR-E-MI-37324 |
| MNDR | hsa-miR-30c-5p | B-cell lymphoma | MNDR-E-MI-37325 |
| MNDR | hsa-miR-30c-5p | Rheumatoid arthritis | MNDR-E-MI-37326 |
| MNDR | hsa-miR-30c-5p | T-cell leukemia | MNDR-E-MI-37327 |
| MNDR | hsa-miR-30c-5p | Retinoblastoma | MNDR-E-MI-37328 |
| MNDR | hsa-miR-30c-5p | Influenza | MNDR-E-MI-37329 |
| MNDR | hsa-miR-30c-5p | Hodgkin lymphoma | MNDR-E-MI-37330 |
| MNDR | hsa-miR-30c-5p | Burkitt lymphoma | MNDR-E-MI-37331 |
| MNDR | hsa-miR-30c-5p | Tonsil cancer | MNDR-E-MI-37332 |
| MNDR | hsa-miR-30c-5p | Psoriasis | MNDR-E-MI-37333 |
| MNDR | hsa-miR-30c-5p | Colorectal cancer | MNDR-E-MI-37334 |
| MNDR | hsa-miR-30c-5p | Nasopharynx carcinoma | MNDR-E-MI-37335 |
| MNDR | hsa-miR-30c-5p | Multiple myeloma | MNDR-E-MI-37336 |
| MNDR | hsa-miR-30c-5p | Acute lymphocytic leukemia | MNDR-E-MI-37337 |
| MNDR | hsa-miR-30c-5p | Diabetic nephropathies | MNDR-E-MI-37338 |
| MNDR | hsa-miR-30c-5p | Ependymoma | MNDR-E-MI-37339 |
| MNDR | hsa-miR-30c-5p | Cardiac hypertrophy | MNDR-E-MI-37340 |
| MNDR | hsa-miR-30c-5p | Nasopharyngeal cancer | MNDR-E-MI-37341 |
| MNDR | hsa-miR-30c-5p | Prostatic neoplasms | MNDR-E-MI-37342 |
| MNDR | hsa-miR-30c-5p | Sclerosis | MNDR-E-MI-37343 |
| MNDR | hsa-miR-30c-5p | Sleep deprivation | MNDR-E-MI-37344 |
| MNDR | hsa-miR-30c-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-37345 |
| MNDR | hsa-miR-30c-5p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-37346 |
| MNDR | hsa-miR-30c-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-37347 |
| MNDR | hsa-miR-30c-5p | Stroke lacunar | MNDR-E-MI-37348 |
| MNDR | hsa-miR-30c-5p | Non-alcoholic fatty liver disease | MNDR-E-MI-37349 |
| MNDR | hsa-miR-30c-5p | Breast cancer her3+ negative | MNDR-E-MI-37350 |
| MNDR | hsa-miR-30c-5p | Cerebellar neurodegeneration | MNDR-E-MI-37351 |
| MNDR | hsa-miR-30c-5p | Duke C | MNDR-E-MI-37352 |
| MNDR | hsa-miR-30c-5p | High grade dysplastic nodule | MNDR-E-MI-37353 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | AC254633.1 | Homo sapiens | RR00032112 |
TOP